270 related articles for article (PubMed ID: 12473880)
1. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families.
de Vos tot Nederveen Cappel WH; Nagengast FM; Griffioen G; Menko FH; Taal BG; Kleibeuker JH; Vasen HF
Dis Colon Rectum; 2002 Dec; 45(12):1588-94. PubMed ID: 12473880
[TBL] [Abstract][Full Text] [Related]
2. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis.
Park JG; Vasen HF; Park KJ; Peltomaki P; Ponz de Leon M; Rodriguez-Bigas MA; Lubinski J; Beck NE; Bisgaard ML; Miyaki M; Wijnen JT; Baba S; Lynch HT
Dis Colon Rectum; 1999 Jun; 42(6):710-5; discussion 715-6. PubMed ID: 10378593
[TBL] [Abstract][Full Text] [Related]
3. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M
Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904
[TBL] [Abstract][Full Text] [Related]
4. In a resource-poor country, mutation identification has the potential to reduce the cost of family management for hereditary nonpolyposis colorectal cancer.
Goldberg PA; Madden MV; Harocopos C; Felix R; Westbrook C; Ramesar RS
Dis Colon Rectum; 1998 Oct; 41(10):1250-3; discussion 1253-5. PubMed ID: 9788388
[TBL] [Abstract][Full Text] [Related]
5. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D
JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431
[TBL] [Abstract][Full Text] [Related]
6. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
[TBL] [Abstract][Full Text] [Related]
7. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
[TBL] [Abstract][Full Text] [Related]
8. Hereditary non-polyposis colorectal cancer (HNPCC): new germline mutation (190-191 del AA) in the human MLH1 gene and review of clinical guidelines for surveillance of affected families.
Schiemann U; Papatheodorou L; Glasl S; Gross M
Eur J Med Res; 2001 Mar; 6(3):93-100. PubMed ID: 11309221
[TBL] [Abstract][Full Text] [Related]
9. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
10. Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population.
Shashidharan M; Smyrk T; Lin KM; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lynch HT
Dis Colon Rectum; 1999 Jun; 42(6):722-6. PubMed ID: 10378595
[TBL] [Abstract][Full Text] [Related]
11. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT
J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610
[TBL] [Abstract][Full Text] [Related]
12. Germline mutations of hMLH1 and hMSH2 genes in patients with suspected hereditary nonpolyposis colorectal cancer and sporadic early-onset colorectal cancer.
Yuan Y; Han HJ; Zheng S; Park JG
Dis Colon Rectum; 1998 Apr; 41(4):434-40. PubMed ID: 9559627
[TBL] [Abstract][Full Text] [Related]
13. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations.
Syngal S; Weeks JC; Schrag D; Garber JE; Kuntz KM
Ann Intern Med; 1998 Nov; 129(10):787-96. PubMed ID: 9841584
[TBL] [Abstract][Full Text] [Related]
14. Patterns of surgery in patients belonging to amsterdam-positive families.
Van Dalen R; Church J; McGannon E; Fay S; Burke C; Clark B
Dis Colon Rectum; 2003 May; 46(5):617-20. PubMed ID: 12792437
[TBL] [Abstract][Full Text] [Related]
15. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population.
Lin KM; Shashidharan M; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lanspa SJ; Lemon SJ; Watson P; Lynch HT
Dis Colon Rectum; 1998 Apr; 41(4):428-33. PubMed ID: 9559626
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.
Hendriks YM; Wagner A; Morreau H; Menko F; Stormorken A; Quehenberger F; Sandkuijl L; Møller P; Genuardi M; Van Houwelingen H; Tops C; Van Puijenbroek M; Verkuijlen P; Kenter G; Van Mil A; Meijers-Heijboer H; Tan GB; Breuning MH; Fodde R; Wijnen JT; Bröcker-Vriends AH; Vasen H
Gastroenterology; 2004 Jul; 127(1):17-25. PubMed ID: 15236168
[TBL] [Abstract][Full Text] [Related]
17. Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in The Netherlands.
Vasen HF; den Hartog Jager FC; Menko FH; Nagengast FM
Am J Med; 1989 Mar; 86(3):278-81. PubMed ID: 2919609
[TBL] [Abstract][Full Text] [Related]
18. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of molecular diagnosis in hereditary nonpolyposis colorectal cancer.
Möslein G
Recent Results Cancer Res; 2003; 162():73-8. PubMed ID: 12790322
[TBL] [Abstract][Full Text] [Related]
20. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
